A PHASE-II STUDY OF 4-EPI-ADRIAMYCIN IN ADVANCED UROTHELIAL TRANSITIONAL CELL-CANCER EORTC-GU GROUP PROTOCOL-30867

被引:12
作者
FOSSA, SD
SPLINTER, T
ROOZENDAAL, KJ
VEENHOF, KHN
PAVONEMACALUSO, M
CALCIATI, A
DEPAUW, M
SYLVESTER, R
机构
[1] ONZE LIEVE KROUWE GASTHUIS,AMSTERDAM,NETHERLANDS
[2] SAN GIOVANNI HOSP,TORINO,ITALY
[3] UNIV AMSTERDAM,ACAD MED CTR,1105 AZ AMSTERDAM,NETHERLANDS
[4] UNIV PALERMO,DEPT UROL,I-90134 PALERMO,ITALY
[5] EUROPEAN ORG RES TREATMENT CANC DATA CTR,BRUSSELS,BELGIUM
[6] ERASMUS UNIV,HOSP DIJKZIGT,ROTTERDAM,NETHERLANDS
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 02期
关键词
D O I
10.1016/0277-5379(89)90035-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:389 / 390
页数:2
相关论文
共 6 条
[1]  
GADELMAWLA N, 1988, P ASCO, V7, P123
[2]   CLINICAL TOXICITY OF 4'-EPI-DOXORUBICIN (EPIRUBICIN) [J].
GANZINA, F ;
DIPIETRO, N ;
MAGNI, O .
TUMORI, 1985, 71 (03) :233-240
[3]  
Niijima T, 1986, Hinyokika Kiyo, V32, P1359
[4]  
TRIPI M, 1986, UROLOGIA, V53, P668
[5]  
YAGODA A, 1987, CANCER, V60, P574, DOI 10.1002/1097-0142(19870801)60:3+<574::AID-CNCR2820601524>3.0.CO
[6]  
2-C